Research Article
Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung Adenocarcinoma
Table 3
Univariate and multivariate analysis of different prognostic factors for disease specific survival in patients with LUAD.
| Characteristics | Total () | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| Gender | 491 | | | | | Female | 262 | Reference | | | | Male | 229 | 0.989 (0.687-1.424) | 0.954 | | | Age | 481 | | | | | ≤65 | 243 | Reference | | | | >65 | 238 | 1.013 (0.701-1.464) | 0.944 | | | Pathologic stage | 483 | | | | | Stage I & stage II | 389 | Reference | | | | Stage III & stage IV | 94 | 2.436 (1.645-3.605) | <0.001 | 2.322 (1.562-3.450) | <0.001 | NPSR1-AS1 | 491 | | | | | Low | 251 | Reference | | | | High | 240 | 1.460 (1.013-2.105) | 0.043 | 1.370 (0.943-1.988) | 0.098 |
|
|